Opthea Limited (OPT) DCF Valuation

Opthea Limited (OPT) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Opthea Limited (OPT) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial prospects of Opthea Limited (OPT) with our user-friendly DCF Calculator! Enter your assumptions regarding growth rates, profit margins, and expenses to calculate the intrinsic value of Opthea Limited (OPT) and inform your investment decisions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .1 .1 .1 .1 .1 .1 .1 .1 .1 .1
Revenue Growth, % 0 -36.96 35.95 28.88 -22.65 1.31 1.31 1.31 1.31 1.31
EBITDA -15.5 -32.9 -82.8 -138.8 -124.4 -.1 -.1 -.1 -.1 -.1
EBITDA, % -17079.2 -57455.77 -106489.56 -138554.61 -160443.72 -100 -100 -100 -100 -100
Depreciation .1 .1 .1 .1 .1 .1 .1 .1 .1 .1
Depreciation, % 98.71 155.46 86.43 93.38 82.64 92.23 92.23 92.23 92.23 92.23
EBIT -15.6 -32.9 -82.9 -138.9 -124.4 -.1 -.1 -.1 -.1 -.1
EBIT, % -17177.91 -57611.24 -106575.99 -138647.99 -160526.36 -100 -100 -100 -100 -100
Total Cash 38.6 97.9 40.4 83.3 107.2 .1 .1 .1 .1 .1
Total Cash, percent .0 .2 .1 .1 .1 .0 .0 .0 .0 .0
Account Receivables 5.5 .0 .0 4.1 7.4
Account Receivables, % 6043.57 0 0 4072.22 9484.89
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 0.00108718 0 0.000620489815 0 0.000341534173 0.000341534173 0.000341534173 0.000341534173 0.000341534173
Accounts Payable 2.5 1.5 7.1 11.1 23.7 .1 .1 .1 .1 .1
Accounts Payable, % 2778.61 2628.5 9118.3 11071.39 30529.44 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -2.51 -18.51 -18.65 -20.25 -26.86 -17.36 -17.36 -17.36 -17.36 -17.36
Tax Rate, % 4.1 4.1 4.1 4.1 4.1 4.1 4.1 4.1 4.1 4.1
EBITAT -10.3 -29.7 -77.6 -133.4 -119.3 -.1 -.1 -.1 -.1 -.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -13.2 -25.2 -72.0 -133.4 -110.0 -16.3 .0 .0 .0 .0
WACC, % 12.25 13.38 13.54 13.65 13.65 13.3 13.3 13.3 13.3 13.3
PV UFCF
SUM PV UFCF -14.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -14
Net Debt -19
Equity Value 5
Diluted Shares Outstanding, MM 80
Equity Value Per Share 0.06

What You Will Receive

  • Comprehensive Financial Model: Utilizes Opthea Limited’s (OPT) actual data for accurate DCF valuation.
  • Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Instant updates allow you to view results immediately as adjustments are made.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Adaptable and Reusable: Designed for versatility, enabling multiple uses for thorough forecasting.

Key Features

  • Comprehensive Historical Data: Opthea Limited’s (OPT) past financial statements and pre-filled projections.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
  • Real-Time Valuation: Instantly view the recalculated intrinsic value of Opthea Limited (OPT).
  • Visual Insights: Dashboard charts present valuation outcomes and essential metrics clearly.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Opthea Limited (OPT) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Opthea Limited’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose Opthea Limited (OPT)?

  • Innovative Solutions: Benefit from cutting-edge therapies tailored for eye diseases.
  • Proven Efficacy: Clinical trials demonstrate the effectiveness of our treatments.
  • Patient-Centric Approach: We prioritize the needs and experiences of our patients.
  • Expert Team: Our professionals are leaders in ophthalmology and biotechnology.
  • Strong Commitment: Dedicated to advancing research and improving patient outcomes.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Opthea Limited (OPT) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Opthea Limited (OPT).
  • Consultants: Deliver professional valuation insights on Opthea Limited (OPT) to clients quickly and accurately.
  • Business Owners: Understand how biopharmaceutical companies like Opthea Limited (OPT) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Opthea Limited (OPT).

What the Template Contains

  • Pre-Filled Data: Includes Opthea Limited’s historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Opthea Limited’s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.